SCHEMBL17429698

SCHEMBL17429698

COC(=O)c1ccc2c(c1)-c1c(C)nc(C)nc1CCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
SPR P35270 1/20 0.37
KDM4E B2RXH2 3/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 2/20 0.36
BRD4 O60885 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ACHE P22303 1/20 0.36
SRD5A1 P18405 1/20 0.36
SRD5A2 P31213 1/20 0.36
MAPK14 Q16539 2/20 0.36
TRPA1 O75762 2/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17400116 0.89 SPR (0.39) LMNASPRKDM4EMEN1KMT2A
SCHEMBL17385898 0.89 ACHE (0.40) LMNASPRKDM4EMEN1KMT2A
SCHEMBL17400099 0.81 ALDH1A1 (0.48) LMNAKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL17385894 0.80 SCARB1 (0.39) LMNASPRKDM4EATMBRD4
SCHEMBL17385851 0.78 ALDH1A1 (0.39) LMNAKDM4EKMT2ASMN1; SMN2ALDH1A1
SCHEMBL17429705 0.78 LMNA (0.41) LMNASPRKDM4EMEN1KMT2A
SCHEMBL17385912 0.76 LMNA (0.41) LMNASPRKDM4EMEN1KMT2A
SCHEMBL17429653 0.75 TDP1 (0.41) LMNAMEN1KMT2ASMN1; SMN2NFKB1
SCHEMBL17385788 0.75 ALDH1A1 (0.42) LMNASPRKDM4EMEN1KMT2A
SCHEMBL17386058 0.74 CA12 (0.41) LMNAKDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 LMNA 2845/4885SPR 2161/4885KDM4E 3682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.